Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo. Try Elite Free for 7 Days
Login Sign up free
Home Screener Maps Charts News Groups Insider Futures Forex Crypto Portfolio Calendar
Pricing

New upgrade:   Journal your trades with more detail

Read How
Market News Market Pulse Stocks News ETF News Crypto News

MacroGenics, Inc.

Contributing Author

Recent Articles by MacroGenics, Inc.

Aug-13
MacroGenics Reports Second Quarter 2026 Financial Results, Streamlined Operating Model and Strengthened Financial Position MGNX GlobeNewswire
Aug-11
MacroGenics Announces Achievement of $10 Million Milestone Following Gilead's Exercise of Option to License Preclinical Bispecific Program MGNX GlobeNewswire
Jul-23
MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026 MGNX -6.74% MGNX -7.73% GlobeNewswire
Jul-02
MacroGenics Completes Sale of GMP Manufacturing Operations to Bora Pharmaceuticals MGNX GlobeNewswire
Jun-22
MacroGenics to Receive Milestone Payment from Sanofi for Recent TZIELD Approval MGNX +10.90% GlobeNewswire
May-14
MacroGenics to Participate in the Stifel 2026 Virtual Targeted Oncology Forum MGNX +20.58% GlobeNewswire
May-13
MacroGenics Reports First Quarter 2026 Financial Results and Highlights Business Transformation MGNX GlobeNewswire
May-11
MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals MGNX MGNX +19.32% GlobeNewswire
May-04
MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ Royalty Purchase Agreement MGNX GlobeNewswire
Apr-08
FDA Removes Partial Clinical Hold on MacroGenics' LINNET Study MGNX GlobeNewswire
Mar-09
MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures MGNX +5.83% MGNX +45.34% GlobeNewswire
Feb-26
MacroGenics to Participate in Upcoming Investor Conferences MGNX GlobeNewswire
Feb-23
MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial MGNX GlobeNewswire
Nov-25
MacroGenics to Participate in the 8th Annual Evercore Healthcare Conference MGNX GlobeNewswire
Nov-12
MacroGenics Reports Third Quarter 2025 Financial Results and Provides Update on Corporate Progress MGNX MGNX +8.84% GlobeNewswire
Nov-06
MacroGenics to Participate in the Stifel 2025 Healthcare Conference MGNX -5.56% GlobeNewswire
Sep-02
MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference MGNX MGNX +9.77% GlobeNewswire
Aug-14
MacroGenics Reports Second Quarter 2025 Financial Results and Highlights Key Strategic Priorities MGNX GlobeNewswire
Aug-13
MacroGenics Appoints Eric Risser as President and Chief Executive Officer MGNX +12.93% GlobeNewswire
Jun-10
MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ Royalty Purchase Agreement MGNX +8.54% GlobeNewswire
Jun-03
MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 MGNX +8.63% GlobeNewswire
May-13
MacroGenics Provides Update on Corporate Progress and First Quarter 2025 Financial Results MGNX GlobeNewswire
May-06
MacroGenics Announces Date of First Quarter 2025 Financial Results MGNX -10.37% GlobeNewswire
May-01
MacroGenics to Participate in Upcoming Investor Conference MGNX GlobeNewswire
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)